首页|特定电磁波谱治疗仪照射联合硫酸镁湿敷对乳腺癌术后化疗患者化疗性静脉炎发生率的影响

特定电磁波谱治疗仪照射联合硫酸镁湿敷对乳腺癌术后化疗患者化疗性静脉炎发生率的影响

扫码查看
目的 探讨特定电磁波谱治疗仪照射联合硫酸镁湿敷对乳腺癌术后化疗患者化疗性静脉炎发生率的影响.方法 采用前瞻性、随机对照试验设计,研究时间为2023年1月至 2024 年 6 月.将医院收治的 160 例乳腺癌术后化疗患者按 1∶1 比例随机分为对照组和观察组,每组 80 例.对照组给予常规护理,观察组在对照组基础上给予特定电磁波谱治疗仪照射联合硫酸镁湿敷.比较两组化疗性静脉炎发生率、疼痛程度、满意度及不良反应发生率.结果 观察组化疗性静脉炎累积发生率低于对照组(P<0.05).化疗结束后第7、14天,观察组静脉炎发生率为5.0%、15.0%,低于对照组的22.5%、36.3%(P<0.05).化疗结束后第1、3、5、7 天,观察组的视觉模拟评分法(VAS)评分均低于对照组(P<0.05).观察组的总满意度为 92.5%,高于对照组的 77.5%(P<0.05).两组均未发生严重不良反应.结论 特定电磁波谱治疗仪照射联合硫酸镁湿敷可有效预防乳腺癌术后化疗患者发生化疗性静脉炎,并可减轻疼痛程度,提高患者的满意度,且安全性良好.
The Effect of Specific Electromagnetic Spectrum Therapeutic Apparatus Irradiation Combined with Magnesium Sulfate Wet Compress on the Incidence of Chemotherapeutic Phlebitis in Patients with Breast Cancer Undergoing Chemotherapy after Surgery
Objective To investigate the effect of specific electromagnetic spectrum therapeutic apparatus irradiation combined with magnesium sulfate wet compress on the incidence of chemotherapeutic phlebitis in patients with breast cancer undergoing postoperative chemotherapy.Methods With the prospective,randomized controlled trial design adopted,the research period was set from January 2023 to June 2024.A total of 160 patients with breast cancer undergoing postoperative chemotherapy admitted to the hospital were randomly divided into the control group and the observation group at a ratio of 1:1,with 80 cases in each group.With routine care in the control group,and specific electromagnetic spectrum therapeutic apparatus irradiation combined with magnesium sulfate wet compress on the basis of the control group in the observation group,the incidence of chemotherapeutic phlebitis,the degree of pain,satisfaction,and incidence of adverse reactions were compared between two groups.Results The cumulative incidence of chemotherapeutic phlebitis in the observation group was lower than that in the control group(P<0.05).On the 7th and 14th days after chemotherapy,the incidences of phlebitis in the observation group were 5.0%and 15.0%,respectively,which were lower than the 22.5%and 36.3%in the control group(P<0.05).On the 1st,3rd,5th,and 7th days after chemotherapy,the visual analog scale(VAS)scores of the observation group were lower than those of the control group(P<0.05).The overall satisfaction rate of the observation group was 92.5%,which was higher than the 77.5%in the control group(P<0.05).No serious adverse reactions occurred in the two groups.Conclusion Specific electromagnetic spectrum therapeutic apparatus irradiation combined with magnesium sulfate wet compress can effectively prevent chemotherapeutic phlebitis in postoperative chemotherapy patients with breast cancer,reduce pain and improve patient satisfaction,with good security.

Specific electromagnetic spectrum therapy deviceMagnesium sulphateBreast cancerChemotherapyPhlebitis

张勇

展开 >

湖北省钟祥市中医院(湖北钟祥 431900)

特定电磁波谱治疗仪 硫酸镁 乳腺癌 化疗 静脉炎

2024

医疗装备
国家食品药品监督管理局北京医疗器械质量监督检验中心 北京市医疗器械检验所

医疗装备

影响因子:0.339
ISSN:1002-2376
年,卷(期):2024.37(21)